Ligand profile
AH4
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03495 — Histone deacetylase superfamily protein
Identifiers
Database identifiers and provenance.
- Ligand ID
AH4- PDB
5wgl- UniProt (similar protein)
F8W4B7- Target protein
- KP13_03495
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 107.5
- −1 ≤ LogP ≤ 5 4.13
- MW ≤ 500 Da 433.5
- LogP ≤ 5 4.13
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 107.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)N(c2ccccc2)c3ncc(cn3)C(=O)NCCCCCCC(=O)NOc1ccc(cc1)N(c2ccccc2)c3ncc(cn3)C(=O)NCCCCCCC(=O)NO
InChI=1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30)InChI=1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30)
QGZYDVAGYRLSKP-UHFFFAOYSA-NQGZYDVAGYRLSKP-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00850
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand AH4 →
- PDB RCSB structure 5wgl →
- UniProt UniProt F8W4B7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “AH4”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03495.
PDB 45
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 55
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).